Vivo Capital’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-13,049
| Closed | -$1.61M | – | 65 |
|
|
2021
Q1 | $1.61M | Hold |
13,049
| – | – | 0.06% | 59 |
|
|
2020
Q4 | $1.48M | Sell |
13,049
-12,255
| -48% | -$1.39M | 0.07% | 55 |
|
|
2020
Q3 | $3.02M | Sell |
25,304
-25,305
| -50% | -$3.02M | 0.17% | 56 |
|
|
2020
Q2 | $6.3M | Sell |
50,609
-2,777
| -5% | -$346K | 0.45% | 43 |
|
|
2020
Q1 | $10.3M | Buy |
+53,386
| New | +$10.3M | 0.93% | 33 |
|
|
2019
Q3 | – | Sell |
-55,712
| Closed | -$24M | – | 28 |
|
|
2019
Q2 | $24M | Hold |
55,712
| – | – | 2.25% | 13 |
|
|
2019
Q1 | $31.5M | Hold |
55,712
| – | – | 3.14% | 10 |
|
|
2018
Q4 | $16.5M | Hold |
55,712
| – | – | 2.11% | 13 |
|
|
2018
Q3 | $39.5M | Hold |
55,712
| – | – | 3.98% | 8 |
|
|
2018
Q2 | $32.6M | Hold |
55,712
| – | – | 4.2% | 6 |
|
|
2018
Q1 | $151M | Buy |
+55,712
| New | +$151M | 21.35% | 1 |
|